Stocks
Immunome (IMNM) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.20 | 3.19 | 1.98 | 0.55 | 1.25 | 1.30 | |||
| Changes by years, y/y, % | +243% | +1 469% | -38% | -72% | +127% | +84.1% | |||
Immunome. Debt/EBITDA
Immunome. Debt/EBITDA, changes, %
Immunome (IMNM) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 1.51 | 1.46 | 4.06 | 1.25 | 1.30 | 1.30 | ||
| Changes by years, y/y, % | +14% | +50% | +450% | +127% | -14% | |||
| Changes by quarters, q/q, % | +174% | -4% | +179% | -69% | +4% | |||
